Correlation of adenoassociated virus type 2 and high-risk human papillomavirus type 16 and 18 infection in the cervix of Korean women.
- Author:
Sung Ha LEE
1
;
Byung Hoon KIM
;
Sun Young KWAK
;
Su Mi BAE
;
Dong Jae KIM
;
Young Wook KIM
;
Joon Mo LEE
;
Sung Eun NAMKOONG
;
Kye Hyun NAM
;
Young Lae CHO
;
Ho Sun CHOI
;
Chong Kook KIM
;
Byoung Don HAN
;
Woong Shick AHN
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, College of Medicine, The Catholic University of Korea. ahnws@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Adenoassocited virus;
Human papillomavirus;
Cervical intraepithelial neoplasm;
Cervical cancer;
PCR
- MeSH:
Cervical Intraepithelial Neoplasia;
Cervix Uteri*;
Female;
Human papillomavirus 16;
Human papillomavirus 18;
Humans*;
Polymerase Chain Reaction;
Uterine Cervical Neoplasms
- From:Korean Journal of Obstetrics and Gynecology
2005;48(2):334-341
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: Previous studies were showed that adenoassocited virus (AAV) infection was had negative effects on human papillomavirus (HPV) infection and that the cervical cancer cell growth is inhibited by AAV infection. We detected of AAV 2 and high-risk HPV infection and researched correlation with AAV 2 and HPV in cervical cell. METHODS: Cell of normal cervix (49 persons), infected HPV cervix (45 persons), cervical intraepithelial neoplasm (CIN) I (31 persons), II (20 persons), III (35 persons), and invasive cancer (30 persons) were investigated by PCR using AAV-2 and HPV type 16 and 18 specific primers. RESULTS: AAV 2 was detected in 8 out of 49 normal cervix (16.3%), 2 out of 45 infected HPV cervix (4.4%), 3 out of 31 CIN I (9.7%), 4 out of 20 CIN II (20%), 8 out of 35 CIN III (22.8%), and 3 out of 30 invasive cervical cancer cases (30%). However, HPV 16 was detected in 5 out of 49 normal cervix (10.2%), 20 out of 45 infected HPV cervix (44.4%), 13 out of 31 CIN I (42%), 11 out of 20 CIN II (55%), 19 out of 35 CIN III (54.3%), and 21 out of 30 invasive cervical cancer cases (70%). HPV 18 was detected in 6 out of 49 normal cervix (12.2%), 18 out of 45 infected HPV cervix (40%), 16 out of 31 CIN I (51.6%), 10 out of 20 CIN II (50%), 22 out of 35 CIN III (62.8%), and 13 out of 30 invasive cervical cancer cases (43.3%). CONCLUSION: AAV 2 was detected in normal and infected HPV cervix, CIN (I, II, III) and invasive cervical cancer. As compared to normal, CIN I and CIN II, suggesting significant correlation between AAV 2 and HPV type 16. Further, researches continue to be done relationship to AAV 2 and HPV infection in cervix.
